Latest news
Oak Hill Bio merges with RA Capital SPAC; InnoCare’s TYK2 drug hits in Phase 3 - Endpoints NewsEndpoints News · Tue, 28 Jul 2026 07:00:00 GMTOak Hill takes SPAC track to Nasdaq with Roche asset in tow - BioSpaceBioSpace · Tue, 28 Jul 2026 07:00:00 GMTOak Hill to get $175M cash infusion in merger with RA Capital-backed SPAC - FirstWord PharmaFirstWord Pharma · Tue, 28 Jul 2026 00:00:14 GMTWilson Sonsini Advises Oak Hill Bio on IP Matters in Proposed Business Combination with RACC - Wilson SonsiniWilson Sonsini · Mon, 27 Jul 2026 23:09:12 GMTRA Capital launches Oak Hill Bio onto the Nasdaq via SPAC - Fierce BiotechFierce Biotech · Mon, 27 Jul 2026 19:25:29 GMTCambridge biotech to go public via RA Capital-backed SPAC - The Business JournalsThe Business Journals · Mon, 27 Jul 2026 18:40:00 GMT